IMS Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,715
| Closed | -$227K | – | 139 |
|
|
2024
Q4 | $227K | Buy |
1,715
+1
| +0.1% | +$132 | 0.11% | 127 |
|
|
2024
Q3 | $250K | Buy |
1,714
+2
| +0.1% | +$291 | 0.11% | 125 |
|
|
2024
Q2 | $252K | Sell |
1,712
-800
| -32% | -$118K | 0.12% | 123 |
|
|
2024
Q1 | $345K | Sell |
2,512
-8
| -0.3% | -$1.1K | 0.16% | 104 |
|
|
2023
Q4 | $342K | Buy |
2,520
+84
| +3% | +$11.4K | 0.17% | 107 |
|
|
2023
Q3 | $298K | Buy |
+2,436
| New | +$298K | 0.18% | 102 |
|
|
2022
Q1 | – | Sell |
-1,582
| Closed | -$241K | – | 145 |
|
|
2021
Q4 | $241K | Hold |
1,582
| – | – | 0.12% | 125 |
|
|
2021
Q3 | $256K | Buy |
+1,582
| New | +$256K | 0.15% | 117 |
|